Free Trial

Silk Road Medical (SILK) Stock Price, News & Analysis

$27.02
0.00 (0.00%)
(As of 09/6/2024 ET)
Today's Range
$27.00
$27.10
50-Day Range
$26.95
$27.24
52-Week Range
$6.08
$27.34
Volume
1.41 million shs
Average Volume
1.24 million shs
Market Capitalization
$1.10 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.29

Silk Road Medical MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.78 Rating Score
Upside/​Downside
24.9% Downside
$20.29 Price Target
Short Interest
Bearish
7.85% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
1.70mentions of Silk Road Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$63,245 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.45) to ($1.33) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.66 out of 5 stars

Medical Sector

613th out of 910 stocks

Surgical & Medical Instruments Industry

71st out of 95 stocks

SILK stock logo

About Silk Road Medical Stock (NASDAQ:SILK)

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

SILK Stock Price History

SILK Stock News Headlines

Silk Road Medical (SILK) Receives a Hold from Lake Street
NASDAQ to crash 50%?
During the 2020 Covid Crash he called a market reversal - eleven days before the S&P bottomed out... Now, he's saying there are four major cracks forming in the US economy...
Argus Research Releases a Buy Rating on Medtronic (MDT)
NASDAQ to crash 50%?
During the 2020 Covid Crash he called a market reversal - eleven days before the S&P bottomed out... Now, he's saying there are four major cracks forming in the US economy...
See More Headlines
Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/07/2024
Today
9/07/2024
Next Earnings (Estimated)
11/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:SILK
Employees
410
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.29
High Stock Price Target
$27.50
Low Stock Price Target
$8.00
Potential Upside/Downside
-24.9%
Consensus Rating
Reduce
Rating Score (0-4)
1.78
Research Coverage
9 Analysts

Profitability

Net Income
$-55,740,000.00
Pretax Margin
-29.53%

Debt

Sales & Book Value

Annual Sales
$191.43 million
Book Value
$3.88 per share

Miscellaneous

Free Float
37,906,000
Market Cap
$1.07 billion
Optionable
Optionable
Beta
1.53
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

SILK Stock Analysis - Frequently Asked Questions

How have SILK shares performed this year?

Silk Road Medical's stock was trading at $12.27 at the start of the year. Since then, SILK stock has increased by 120.2% and is now trading at $27.02.
View the best growth stocks for 2024 here
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) issued its earnings results on Wednesday, August, 7th. The company reported ($0.42) earnings per share for the quarter, missing the consensus estimate of ($0.38) by $0.04. The business's revenue was up 13.0% on a year-over-year basis.

When did Silk Road Medical IPO?

Silk Road Medical (SILK) raised $75 million in an IPO on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

Who are Silk Road Medical's major shareholders?

Silk Road Medical's top institutional shareholders include Magnetar Financial LLC (4.85%), Glazer Capital LLC (1.53%), Renaissance Technologies LLC (1.23%) and Marshall Wace LLP (1.08%). Insiders that own company stock include Lucas W Buchanan, Andrew S Davis, Erica J Rogers, Kevin M Klemz, Richard Ruedy, Marie L Jones and Tony M Chou.
View institutional ownership trends
.

How do I buy shares of Silk Road Medical?

Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Silk Road Medical investors own include RTX (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW) and

This page (NASDAQ:SILK) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners